Protective effect of doxycycline use on coronary artery disease?

Journal of Infection

Volumn 52, Issue 4, 2006, Pages 243-246

  Kardara, Marina ^a   Papazafiropoulou, Athanasia ^a   Katsakiori, Paraskevi ^a   Petropoulos, Chrysanthos ^a   Jelastopulu, Eleni ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

CAD; Chlamydia pneumoniae; Coronary artery disease; Doxycycline

Indexed keywords

DOXYCYCLINE; RIFAMPICIN;

ACUTE HEART INFARCTION; ADULT; AGED; BRUCELLOSIS; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA BASE; DEATH; DRUG USE; FEMALE; GENERAL PRACTICE; GREECE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRESCRIPTION; REVIEW; RISK FACTOR; RISK REDUCTION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

EID: 33645284150     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.07.003     Document Type: Article

References (19)

1. S. Gupta A.J. Camm Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: A critical overview Coron Artery Dis 9 1998 339-343
2. W. Valtonen Role of infections in atherosclerosis Am Heart J 138 1999 431-433
3. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115-126
4. R.G. Gibbs N. Carey A.H. Davies Chlamydia pneumoniae and vascular disease Br J Surg 85 1998 1191-1197
5. P. Saikku M. Leinonen K. Mattila M.R. Ekman M.S. Nieminen P.H. Makela et. al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction Lancet 2 1988 983-986
6. P. Saikku M. Leinonen L. Tenkanen E. Linnanmaki M.R. Ekman V. Manninen et. al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study Ann Intern Med 116 1992 273-278
7. M.A. Mendall D. Carrinton D. Strachan P. Patel N. Molineaux J. Levi Chlamydia pneumoniae: Risk factors for seropositivity and associations with coronary artery disease J Infect 30 1995 121-128
8. D.H. Thon J.T. Grayston D.S. Siscovick S.P. Wang N.S. Weiss J.R. Daling Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease J Am Med Assoc 268 1992 68-72
9. S. Gupta E.W. Leatham D. Carrington M.A. Mendall J.C. Kaski A.J. Camma Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction Circulation 96 1997 404-407
10. E. Gurfinkel G. Bozovich E. Beek B. Livellara B. Mautner Treatment with the antibiotic roxithromycin in patients with acute non Q-wave coronary symptoms. The final report of the ROXIS study Eur Heart J 20 1999 121-127
11. J.L. Anderson J.B. Muhlestein J. Carlquist A Allen S Trehan C Nielson et. al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The azithromycin in coronary artery disease: Elimination of myocardial infection with Chlamydia (ACADEMIC) study Circulation 99 1999 1540-1547
12. C.R. Meier L.E. Derby S.S. Jick C. Vasilakis H. Jick Antibiotics and risk of subsequent first-time acute myocardial infarction J Am Med Assoc 281 1999 427-431
13. L.A. Jackson N.L. Smith S.R. Heckbert J.T. Grayston D.S. Siscovick B.M. Psaty Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline Emerg Infect Dis 5 1999 281-284
14. M.R. Hammerschlag K. Chirgwin P.M. Roblin M Gelling W Dumornay L Mandel et. al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness Clin Infect Dis 14 1992 178-182
15. M.R. Hammerschlag K.K. Qumei P.M. Roblin In vitro activities of azithromycin, clarithromycin, l -ofloxacin, and other antibiotics against Chlamydia pneumoniae Antimicrob Agents Chemother 36 1992 1573-1574
16. A.S. Beale N.D. Masson Susceptibility of Chlamydia pneumoniae to oral agents commonly used in the treatment of respiratory infection J Antimicrob Chemother 34 1994 1072-1075
17. M.R. Hammerschlag Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae Antimicrob Agents Chemother 38 1994 1873-1878
18. C. Kuo L.A. Jackson A. Lee J.T. Grayston In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae Antimicrob Agents Chemother 40 1996 2669-2670
19. J. Gieffers W. Solbach M. Maass In vitro susceptibilities of Chlamydia pneumoniae strains recovered from atherosclerotic coronary arteries Antimicrob Agents Chemother 42 1998 2762-2764